BioNTech Stock Boosted by COVID-19 Vaccine Pact

BNTX is up nearly 80% this year

Deputy Editor
Sep 8, 2020 at 10:51 AM
facebook X logo linkedin


The shares of BioNTech SE (NASDAQ:BNTX) are up 1.4% at $59.42 at last check, after the company was one of nine biopharmaceutical companies to announce a united commitment to uphold the integrity of the scientific process while working toward a COVID-19 vaccine.This pact comes amid a heated debate over what drug companies should be doing to stop the spread of the coronavirus. 

Today's pop has BNTX contending with its 100-day moving average -- a trendline that's served as resistance since late last month. While the security has definitely taken a tumble off its mid-July peak near the $104 mark, it is up around 79.4% this year. 

On the analyst front, three out of the seven analysts in coverage sport a "strong buy" on BioNTech stock, with the remaining four at a tepid "hold." Meanwhile, the 12-month consensus target price of $77 is a 30% premium to current levels. 

In the past 10 days, 1.22 calls have been bought for every put at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). These options are reasonably priced at the moment too, per the stock's Schaeffer's Volatility Index (SVI) of 104%, which sits in the 24th percentile of its annual range. This suggests short-term options players are pricing in relatively low volatility expectations. 

 

 

Unlock Weekend Profits with Chris Prybal's Favorite Strategy Up +487.5% in 2024

With the markets going left, right, and sideways, you need to have a plan now more than ever. 

Expert Trader Chris Prybal is no stranger to volatility, and has mastered finding big stock rallies while other traders aren't looking over the weekend. Rallies that produced gains like +207% on RTX calls, +236% on MARA calls, and +238% on NET calls.

A few simple moves on Sunday at 7pm could be the “Secret Sauce” your portfolio needs to not just stay afloat, but make unprecedented gains in this turbulent market.


Don’t sit on the sidelines, beat the market with Chris Prybal's strategy. Join him now!

 

 
 
 


 
 

Rainmaker Ads CGI